Dow's J&J Flirts With Buy Point On Bullish Pre-Earnings Report

Johnson & Johnson (JNJ) flirted with a buy point Thursday on another bullish report citing strength in its pharmaceutical unit ahead of the Dow component's third-quarter earnings, slated for early Tuesday.

XAutoplay: On | OffIn early trading on the stock market today, J&J advanced 0.2%, near 136.90, though shares briefly topped a 137.18 buy point out of a flat base that began forming in July. Shares are trading at an all-time high.

"We remain bullish on the story, driven in large part by...

What feeling does this article give you?

#hashtags to follow:

JNJ [+]    Dow [+]    XAutoplay [+]   

More #news: